The Utility of Evaluating Low Serum Albumin Gradient Ascites in Patients With Cirrhosis

Size: px
Start display at page:

Download "The Utility of Evaluating Low Serum Albumin Gradient Ascites in Patients With Cirrhosis"

Transcription

1 nature publishing group ORIGINAL CONTRIBUTIONS 1401 The Utility of Evaluating Low Serum Albumin Gradient Ascites in Patients With Cirrhosis Hashim E. K handw a l l a, M D 1, Ye m i Fas a k i n, M D 1 and Hashem B. E l - S e r ag, M D, MPH 1 OBJECTIVES: METHODS: Serum-ascites albumin gradient (SAAG) has been used extensively in the diagnostic wkup of patients with ascites. A SAAG level of < 1.1 g / dl is usually thought of as a result of nonptal hypertension etiologies, including malignancies, tuberculous peritonitis, and nephrotic syndrome. However, the predictive value of a low SAAG in patients with existing cirrhosis in whom the pretest probability of ptal hypertension is high is not clear. We identified all patients with a SAAG of < 1.1 g / dl during a 5-year period at a single large veterans affairs medical center. Cirrhosis was defined by clinical, histological, and radiological features. Nonptal hypertension causes of low SAAG were identified, including bacterial peritonitis, peritoneal carcinomatosis, nephrogenous ascites, tuberculous peritonitis, chylous ascites, and pancreatic ascites. RESULTS: We identified 92 patients (76 with cirrhosis and 16 with no cirrhosis) with ascites and a SAAG of < 1.1 g / dl. Of the 76 patients with cirrhosis, only 29 (38 % ) had an identifiable cause, most commonly primary bacterial peritonitis (11, 38 % ), followed by peritoneal carcinomatosis malignant ascites (8, 28 % ) and nephrotic syndrome (5, 17 % ). There were 47 patients with cirrhosis and a low SAAG f whom no etiology was identified. Thirty-three patients underwent a repeat paracentesis, 24 (73 % ) of whom changed to a high SAAG. On the other hand, the 16 patients with no cirrhosis had significantly lower SAAG (0.66 vs. 0.81), and most (12, 75 % ) had an identifiable cause of ascites. CONCLUSIONS: Evaluation of a SAAG < 1.1 g / dl in patients with known cirrhosis has low yield and is less likely to be helpful than that in patients without cirrhosis. A repeat paracentesis as part of the wkup is recommended. Further studies of low SAAG cutoffs are needed. Am J Gastroenterol 2009; 104: ; doi: /ajg ; published online 21 April 2009 INTRODUCTION Serum-ascites albumin gradient (SAAG) is extensively used in the diagnostic wkup of ascites (1 6). Runyon et al. showed high sensitivity (96.7 % ) f a high SAAG (defined as SAAG 1.1 g / dl) in diagnosing ascites related to ptal hypertension (1). In the same study, the etiologies of low SAAG (defined as SAAG < 1.1 g / dl) in patients without cirrhosis included malignant ascites, tuberculous peritonitis, and nephrotic syndrome. However, the utility of evaluating a low SAAG in patients with known cirrhosis and ptal hypertension has not been adequately established. These patients have been described as having mixed ascites, with the presence of ptal hypertension and a variable SAAG level secondary to another underlying diagnosis (7). In the study conducted by Runyon et al., on ly 42 (4.7 % ) of 901 ascites samples obtained from patients with cirrhosis had mixed ascites. The yield of further wkup to uncover other causes of a low SAAG, including tuberculous peritonitis, peritoneal carcinomatosis, and nephrotic syndrome in patients with cirrhosis, is not clear. We conducted this study to determine the utility of a diagnostic wkup f patients with cirrhosis and a low SAAG and to establish a secondary cause of ascites. We hypothesized that, 1 Sections of Gastroenterology and Health Services Research at the Michael E. DeBakey Veterans Affairs Medical Center and Bayl College of Medicine, Houston, Texas, USA. Crespondence: Hashem B. El-Serag, MD, MPH, Bayl College of Medicine, Medicine, The Michael E. DeBakey Veterans Affairs Medical Center, 2002 Holcombe Boulevard, Houston, Texas 77030, USA. hasheme@bcm.tmc.edu Received 29 October 2008; accepted 12 January 2009

2 1402 Khandwalla et al. in the presence of a high pretest likelihood f ptal hypertension, a low SAAG will have a low predictive value f secondary causes of ascites. METHODS We screened 405 patients at the Michael E. DeBakey Veterans Affairs Medical Center in Houston, TX, who had undergone paracentesis with measurement of both serum and ascites albumin levels between January 2000 and December We identified patients with at least one documented SAAG of < 1.1 g / dl ( n = 92). We conducted systematic abstraction of medical recds to collect infmation on several demographic features, clinical, labaty, pathologic, and radiographic data. We evaluated patients in this study on the basis of the presence of cirrhosis. Cirrhosis was defined as being present on the basis of radiological, pathological, other evidence of the presence of a nodular liver ptal hypertension. On the basis of specific diagnostic criteria ( Table 1 ), we determined whether these patients had an appropriate wkup to establish a secondary cause of a low SAAG. The SAAG results of a repeat paracentesis, if perfmed, were evaluated f patients who initially had an unknown etiology of a low SAAG. We searched f commonly described etiologies f low SAAG levels through ascites fluid analysis f neutrophil count; bacterial and fungal culture; acid-fast bacillus (AFB) culture; fluid cytology and imaging modalities, including ultrasonography, computerized tomography (CT), and magnetic resonance imaging (MRI), to rule out malignancies, peritoneal biopsy where indicated, and urine protein measurement. These etiologies include spontaneous bacterial peritonitis (SBP), secondary bacterial peritonitis, tuberculous peritonitis, nephrogenous ascites, ascites secondary to nephrotic syndrome, malignant ascites peritoneal carcinomatosis, and pancreatic ascites. The diagnosis of SBP was based on bacterial growth in an ascitic fluid collected in blood culture bottles inoculated at the bedside an ascitic absolute neutrophil count of at least cells / l (8). A diagnosis of secondary bacterial peritonitis was made if a perfated viscus, intestinal ischemia, and / obstruction were documented by a radiographic surgical evaluation. The diagnosis of mycobacterial peritonitis required mycobacterial growth in an ascitic fluid culture peritoneal biopsy positive results of a polymerase chain reaction scan of ascitic fluid f a mycobacterium. Mycobacterial peritonitis diagnosis was also made if a mycobacterial smear was positive in the presence of a positive purified protein derivative if ascitic fluid adenosine deaminase level was at least 40 IU / l (9). Nephrogenous ascites was diagnosed in dialysis-related ascites, and ascites resulting from nephrotic syndrome was diagnosed in the presence of 24 h urine collection f protein of at least 3.5 g / day (10) spot urine protein-to-creatinine ratio >3 (11). The diagnosis of Table 1. Diagnostic criteria employed in the study f secondary causes of SAAG < 1.1 g/dl Condition peritonitis Candida peritonitis Nephrotic syndrome Tuberculous peritonitis Pancreatic ascites Chylous ascites Secondary bacterial peritonitis Malignant ascites Diagnosis Ascites fl uid ANC > cells/l Bacterial growth in ascites fl uid Positive ascitic fl uid culture f Candida species 24-h urine protein >3.5 g Spot urine protein/creatinine ratio >3 Positive ascites fl uid AFB smear with positive PPD Positive ascites fl uid culture f MTB Positive PPD and ascites fl uid adenosine deaminase > 40 IU/l Granulomatous infl ammation on peritoneal biopsy Positive ascites fl uid MTB PCR Ascites fl uid amylase level at least twice upper limit of nmal Ascites fl uid triglycerides >200 mg/dl Perfated viscus, ischemia, obstruction on radiographic study Positive ascites fl uid cytology Positive peritoneal biopsy biopsy of gan involved Tum localization as determined by radiographic study AFB, acid-fast bacillus; ANC, absolute neutrophil count; MTB, Mycobacterium tuberculosis ; PCR, polymerase chain reaction; PPD, purifi ed protein derivative; SAAG, serum-ascites albumin gradient. malignant ascites was based on positive cytology of an ascitic fluid (12), positive biopsy of the gan involved, tum localization as determined by CT scan, MRI, laparotomy, autopsy. Pancreatic ascites was diagnosed when the ascitic fluid amylase level was at least twice that of the upper limit of nmal f serum amylase (13). Lastly, the diagnosis of chylous ascites was based on ascitic fluid triglyceride level of at least 200 mg / dl (14). We used standardized comprehensive data collection fms designed in Telefm (Autonomy Cardiff, Vista, CA), which we subsequently scanned into an Access database and converted into SAS (Statistical Analysis Systems, Cary, NC) data sets f statistical analyses. Descriptive statistics were generated: mean and s.d. f continuous variables and proptions f categical variables. We compared patients with and without cirrhosis using chi-square f categical variables and t -test f continuous variables. The American Journal of GASTROENTEROLOGY VOLUME 104 JUNE

3 Utility of Serum Albumin Gradient Ascites 1403 RESULTS Of the 405 patients with ascites, 92 (23 % ) had at least one SAAG level of < 1.1 g / dl, of whom 76 had cirrhosis and 16 did not. There were 83 (90 % ) male patients. The mean age was 59 (s.d. = 10). Most patients (65, 86 % ) had the serum and ascites albumin levels measured < 12 h apart. Low SAAG and cirrhosis We evaluated the 76 patients with cirrhosis and at least one paracentesis yielding a SAAG level of < 1.1 g / dl. The mean SAAG level of these patients was 0.81 (s.d. = 0.21). The most common cause of cirrhosis was alcohol ( n = 35), followed by both chronic hepatitis C virus infection and alcohol abuse as an etiology of their cirrhosis in 27 patients. Six patients had only hepatitis C virus, four had cardiac cirrhosis, two had nonalcoholic fatty liver disease, one had cryptogenic cirrhosis and one patient had chronic hepatitis B virus infection. As stated in the Methods section, we used standard criteria ( Table 1 ) f the determination of low SAAG-level etiologies. Causes of low SAAG ascites were identified in 29 (38 % ) of the 76 patients ( Table 2 ). The mean SAAG level f the patients in whom a cause was identified was 0.72 (s.d. = 0.24), which was significantly lower than the mean SAAG level f patients in whom no cause was identified, which was 0.86 (s.d. = 0.18, P = 0.005). The most common etiology was SBP, which was diagnosed in 11 (38 % ) patients. The remainder had peritoneal carcinomatosis, 8 (28 % ); nephrotic syndrome, 5 (17 % ); tuberculous peritonitis, 3 (10 % ); chylous ascites, 1 (3.5 % ); and a perfated viscous (secondary peritonitis), 1 (3.5 % ). Most patients with peritoneal carcinomatosis (7, 88 % ) had suggestive abdominal imaging studies (ultrasound, CT MRI). In all, 47 (62 % ) of the 76 patients with cirrhosis and a low SAAG had no identifiable cause of the low SAAG on initial wkup ( Figure 1 ), and 33 (70 % ) of these patients had a repeat diagnostic paracentesis. Of these, 24 (73 % ) changed to a SAAG level of 1.1 g / dl; only 9 (27 % ) patients continued to have a low SAAG. Thus, in total, 23 patients with cirrhosis had an unexplainable low SAAG (including the nine patients who had a repeat paracentesis). Seven of these patients had an appropriate complete wkup. On further analysis, 16 patients had a complete wkup, except f AFB culture of the ascites fluid. Low SAAG and no cirrhosis Sixteen patients with a low SAAG had no evidence of cirrhosis. The mean SAAG level of these patients was 0.66 (s.d. = 0.32), which was significantly lower than those observed in patients Table 2. Comparison between two groups of patients with low SAAG accding to the presence of cirrhosis Cirrhosis No cirrhosis P value Number of patients Age (mean ± s.d.) 58 ± ± Male (%) 74 (97%) 9 (75%) < SAAG level (mean ± s.d.) 0.81 ± ± Cause of low SAAG identifi ed (%) peritonitis (%) Other identifi ed secondary causes (%) SAAG, serum-ascites albumin gradient. 29 (38%) 12 (75%) (14%) 1 (6%) (24%) 11 (69%) < Cirrhosis (76) Cause identified (29, 38%) No cause identified (47, 62%) Repeat paracentesis (33, 70%) No repeat paracentesis (14, 30%) Repeat paracentesis SAAG 1.1 g/dl (24, 73%) Did not revert to SAAG 1.1 g/dl (9, 27%) Figure 1. Flow diagram f fi ndings of diagnostic wkup among patients with cirrhosis and SAAG < 1.1 g / dl. SAAG, serum-ascites albumin gradient.

4 1404 Khandwalla et al. Cause identified (12) No Cirrhosis (16) Peritoneal carcinomatosis (7) Secondary peritonitis (2) Chylous ascites (1) Nephrotic syndrome (1) peritonitis (1) No cause identified (4) Figure 2. Flow diagram f results of diagnostic wkup in patients without cirrhosis and SAAG < 1.1 g / dl. SAAG, serum-ascites albumin gradient. with cirrhosis and low SAAG ( P = 0.02) ( Table 2 ). A considerably larger proption of these patients (12, 75 % ) had an identifiable cause of the low SAAG ( Figure 2 ), with peritoneal carcinomatosis being the most common (58 % ), followed by secondary peritonitis (17 % ), chylous ascites (8 % ), nephrotic syndrome (8 % ), and SBP (8 % ). DISCUSSION Low SAAG has a po predictive value in the presence of a low pretest probability f nonptal hypertension-related ascites. In 76 patients with cirrhosis and a low SAAG level, f whom the pretest likelihood f ptal hypertension ascites is high, only 38 % of patients had an identifiable cause, of which primary bacterial peritonitis accounted f 14 %. The commonly sought-after diagnoses of peritoneal carcinomatosis, tuberculous peritonitis, nephrotic syndrome, nephrogenous, and pancreatic ascites were present in only 24 % of the patients with cirrhosis and a low SAAG. In general, patients with cirrhosis and a low SAAG had SAAG values that were slightly lower than 1.1 g / dl (mean, 0.81), and of the 47 patients with no apparent etiology of a low SAAG level, 24 (51 % ) reverted back to a high SAAG level (i.e., 1.1 g / dl) on repeat paracentesis. On the other hand, patients with a low SAAG and no cirrhosis, in whom the pretest likelihood f ptal hypertension ascites is low, had a considerably lower SAAG (mean, 0.66), and most (58 % ) of the patients had an identified cause that was malignancy related. The diagnostic yield of a low SAAG accding to the presence absence of cirrhosis has not been widely addressed. F example, the Mansour Ghanaei et al. study of patients with low SAAG in Nthern Iran found that the most frequent causes of low SAAG were tuberculous peritonitis, followed by malignancy, nephrotic syndrome, and pancreatitis (15). However, concurrent cirrhosis lack of it was not categically mentioned. Nevertheless, the few published data seem to suppt our findings. In the study by Runyon et al. (1), 901 ascites samples were collected, of which 758 (84.1 % ) samples were from patients who had cirrhosis without any other secondary cause of ascites and 42 (4.7 % ) samples were classified as mixed ascites. Tuberculous peritonitis and malignancy / peritoneal carcinomatosis were the most common causes of mixed ascites. The most common reasons f a low SAAG in 42 patients with no cirrhosis were peritoneal carcinomatosis, tuberculous peritonitis, nephrogenous / nephrotic syndrome, and pancreatic ascites (1). Part of our findings pertain to patients with cirrhosis and at least one paracentesis yielding a low SAAG in which no identifiable cause explained the SAAG level of < 1.1 g / dl. We found that approximately 51 % of patients did revert to an expected SAAG of 1.1 g / dl. This is to be expected, given the only modest depression of SAAG in these patients and thus the narrow margin of err required to reach the magical cutoff of 1.1 g / dl. However, a few patients, despite a complete wkup, continued to have an unexplained low SAAG. Several patients in this group with no identifiable etiology did not have an AFB culture. On the basis of the low yield from the rest of the patients who had an AFB culture, it is reasonable to assume that most of these patients would continue to have an unexplained low SAAG level. The actual benefit from wking up a low SAAG in patients with cirrhosis is lower than the 38 % yield we observed. Most of the additional etiologies included in this yield did not require additional wkup: bacterial peritonitis was readily detected by an elevated neutrophil count and routine culture in all cases of primary and secondary peritonitis (12 patients); peritoneal carcinomatosis was highly suggested by abdominal imaging in seven patients; pre-existing nephrotic syndrome was seen in all five patients; and known pulmonary / disseminated tuberculous peritonitis was seen in one patient. Thus, the diagnostic yield may be as low as 5 %. Given that patients with cirrhosis in whom additional etiologies were diagnosed had a mean SAAG level of 0.72, a lower cutoff f SAAG is likely to have a better positive predictive value f nonptal hypertension-related etiologies. This needs to be examined in future studies. The retrospective study design is a potential limitation of the current findings, as it is subjected to variability in the accuracy and completeness of documentation of diagnostic wkup f cirrhosis, as well as low-gradient ascites. A standardized wkup would have ensured unifmity in the interpretation of the wkup of a patient with cirrhosis and a low SAAG. There was also a variance in the collection times of the serum and ascites albumin levels among the study population. However, we are unaware of a systematic bias in which wkup would be me less intense, depending on the presence of cirrhosis and, therefe the effect of the retrospective design on the study findings is unclear. Lastly, it is possible, but not likely, that addi- The American Journal of GASTROENTEROLOGY VOLUME 104 JUNE

5 Utility of Serum Albumin Gradient Ascites 1405 tional diagnostic wkup was conducted in non-va facilities and therefe missed in this study. In summary, among patients with cirrhosis found to have a low SAAG, the overall yield of a wkup f additional causes of low SAAG level is low. The standard wkup f these patients should include analysis of the ascitic fluid f cell count, bacterial culture, albumin, and total protein. A repeat measurement should be perfmed, as reversion to a SAAG of 1.1 g / dl is commonly observed. There is, however, a subset of patients who, despite having an appropriate wkup, may have an unexplained low SAAG level; this additional targeted testing includes amylase, triglyceride, AFB, cytology, and urine proteins. A small percentage of patients with unexplained low SAAG levels do not revert to a high-gradient ascites on repeat paracentesis. The utility of further wkup beyond abdominal imaging to determine the cause of low-gradient ascites in these patients is undefined and is likely to be very low. ACKNOWLEDGMENTS Th is wk was suppted in part by the Houston VA HSR & D Center of Excellence (HFP90-020) and NIH/NIDDK Center Grant P30 DK Dr El-Serag is suppted by NIH K24DK CONFLICT OF INTEREST Guarant of the article: Hashem B. El-Serag, MD, MPH. Specific auth contributions: Hashim Khandwalla and Yemi Fasakin contributed to data collection and analysis and manuscript preparation; Hashem B. El-Serag contributed to data analysis and manuscript preparation. Financial suppt: None. Potential competing interests: None. REFERENCES 1. Runyon BA, Mont ano A A, A k r iv i d is E A et al. The serum-ascites albumin gradient is superi to the exudate-transudate concept in the differential di ag nos is of as c ite s. Ann Inte r n Me d ;1 1 7 : D itt r i ch S, Yd i L M, d e Mat ro s A A. The value of serum-ascites albumin gradient f the determination of ptal hypertension in the diagnosis of as cites. Hep ato g ast ro e nte rol o g y ;4 8 : A lb a J, T re s E, Vas que z J J. S ero -as cit ic gradient of albumin: usefulness and diagnostic limitations. An Med Int 1995 ; 12 : G oy a l A K, G oy a l SK, Pok har na D S et al. D ifferential diagnosis of ascitic fluid: evaluation and comparison of various biochemical criteria with a special reference to serum ascites albumin concentration gradient and its rel at ion to p t a l pre ssu re. Trop G ast ro e nte rol ;1 0 : D as B, Achar y a U, P urohit A. C omp ar at ive ut i l it y of s e ro as c ites albumin gradient and ascitic fluid total protein f differential diagnosis of ascites. Indi an Pe d i at r ;3 5 : L au d an no OM, Bre s c i an i P, Si lv a M. D i ag no st ic efficacy of albumin gradient in different causes of ascites. Acta Gastroenterol Latinoam 1995 ; 25 : R e c t WG, R e y nol ds T B. Sup e r i it y of s e r um-ascites albumin difference over the ascites total protein concentration in separation of transudative and exudative ascites. Am J Med 1984 ; 77 : She e r TA, Runyon BA. Sp ont ane ous b a c te r i a l p e r itonit is. D i g Dis 2005 ;2 3 : Voi g t M D, Ka lv ar i a I, Tre y C et al. D i ag no st ic value of ascites adenosine deaminase in tuberculous peritonitis. Lancet 1989 ; 1 : O r t h SR, R it z E. The nephrotic syndrome. New Engl J Med 1998 ; 338 : L ane C, Brow n M, D u ns mu i r W et al. C an sp ot urine protein/creatinine ratio replace 24 h urine protein in usual clinical nephrology? Nephrology (C arlton ) ;1 1 : Runyon BA, Ho e f s JC, Mg an T R. As c it ic fluid analysis in malignancyrelated ascites. Hepatology 1988 ; 8 : Runyon BA. Amy l as e l e vels in ascitic. J Clin Gastroenterol 1987 ; 9 : C as afont F, L op e z- Ar i as M J, C re sp o J et al. C hy l ous as cites in cirrhotic and non-cirrhotic patients. Gastroenterol Hepatol 1997 ; 20 : Mans ou r- Ghanae i F, Shaf ag h i A, B ag herzadeh AH et al. L ow g radient ascites: a seven-year course review. Wld J Gastroenterol 2005 ; 11 : Study Highlights WHAT IS CURRENT KNOWLEDGE 3 There is high sensitivity f a high serum-ascites albumin gradient (SAAG) ( 1.1 g / dl) in diagnosing ascites related to ptal hypertension. 3 Patients with mixed ascites have ptal hypertension and a variable SAAG level secondary to another underlying diagnosis. WHAT IS NEW HERE 3 Low SAAG has po predictive value f cases in which the patient has a low pretest probability f nonptal hypertension related ascites. 3 In patients with cirrhosis who have a low SAAG, the overall yield of a wkup f additional causes of low SAAG level is low. 3 Repeat measurements should be perfmed; however, a small number of patients will have an unexplained low SAAG level. 3 The usefulness of further wkup beyond abdominal imaging to determine the cause of low-gradient ascites is undefined and likely to be very low.

Ascites Management. Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology

Ascites Management. Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology Ascites Management Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology Disclosure 1. The speaker Atif Zaman, MD MPH have no relevant

More information

aetiology and diagnostic value of

aetiology and diagnostic value of Original Article Singapore Med 1 2007, 48 (5) : 434 Ascites in the state of Qatar: aetiology and diagnostic value of ascitic fluid analysis Khan F Y ABSTRACT Introduction: Ascites is common and represents

More information

Corresponding Author: *Dr. G. Bala Bhaskara Reddy, Associate Professor, Pediatrics, FIMS (Fathima Institute of Medical Sciences, Kadapa, A.P.

Corresponding Author: *Dr. G. Bala Bhaskara Reddy, Associate Professor, Pediatrics, FIMS (Fathima Institute of Medical Sciences, Kadapa, A.P. IOSR Journal of Dental and Medical Sciences (IOSRJDMS) eissn: 227903, pissn: 2279061.Volume 16, Issue 12 Ver. III (Dec. 2017), PP 0107 www.iosrjournals.org Comparative Utility of SAAG (Sero Ascitic Albumin

More information

February 1, 2016 Body Fluid order changes

February 1, 2016 Body Fluid order changes February 1, 2016 Body order changes Laboratory will be making the following changes to Body tests: 1. Changing orders in Power plans (see below list). 2. All folders will be updated accordingly: If the

More information

Original Research Article. Shanker Suman 1 *, Divya Jyoti 2, Pramod Kumar Agrawal 1, Bijoy Kumar Bhattacharya 2

Original Research Article. Shanker Suman 1 *, Divya Jyoti 2, Pramod Kumar Agrawal 1, Bijoy Kumar Bhattacharya 2 International Journal of Advances in Medicine Suman S et al. Int J Adv Med. 2017 Jun;4(3):842-846 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20172282

More information

Etiological factor of ascites and its correlation with serum ascites albumin gradient and cholesterol gradient in patients admitted at rural area

Etiological factor of ascites and its correlation with serum ascites albumin gradient and cholesterol gradient in patients admitted at rural area International Journal of Advances in Medicine Porwal V et al. Int J Adv Med. 2016 Aug;3(3):573-578 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20162497

More information

CLINICAL How Should a Hospitalized Patient with Newly Diagnosed Cirrhosis Be Evaluated and Managed?

CLINICAL How Should a Hospitalized Patient with Newly Diagnosed Cirrhosis Be Evaluated and Managed? CLINICAL How Should a Hospitalized Patient with Newly Diagnosed Cirrhosis Be Evaluated and Managed? The Hospitalist. 2016 August;2016(8) Author(s): Raj Sehgal, MD; Joshua Hanson, MD, MPH; Division OF The

More information

1 yr old girl presented with Fever on and off 3 months H/o frequent semisolid bulky stools 3 months Progressive abdominal distension 3 months Failure

1 yr old girl presented with Fever on and off 3 months H/o frequent semisolid bulky stools 3 months Progressive abdominal distension 3 months Failure Dr Rajasree S Dr Srinivas S, Dr Bagdi RK, Dr Satheesh C Apollo Childrens Hospital, Chennai 1 yr old girl presented with Fever on and off 3 months H/o frequent semisolid bulky stools 3 months Progressive

More information

Management of Cirrhosis Related Complications

Management of Cirrhosis Related Complications Management of Cirrhosis Related Complications Ke-Qin Hu, MD, FAASLD Professor of Clinical Medicine Director of Hepatology University of California, Irvine Disclosure I have no disclosure related to this

More information

Original article Correlation between serum-ascites albumin concentration gradient and endoscopic parameters of portal hypertension

Original article Correlation between serum-ascites albumin concentration gradient and endoscopic parameters of portal hypertension Kathmandu University Medical Journal (005), Vol. 3, No., Issue, 37-333 Original article Correlation between serum-ascites albumin concentration gradient and endoscopic parameters of portal hypertension

More information

Pulmonary Morning Report. Ashley Schmehl D.O. PGY-3 January,

Pulmonary Morning Report. Ashley Schmehl D.O. PGY-3 January, Pulmonary Morning Report Ashley Schmehl D.O. PGY-3 January, 8 2015 Pleural Effusion Unilateral versus Bilateral Associated symptoms Transudate versus Exudate Light s Criteria: Pleural protein: Serum protein

More information

Pleural fluid. creatinine - urinothorax haematocrit -haemothorax bilirubin gut perforation. Fluid samples 1st Plain Universal ( cell count)

Pleural fluid. creatinine - urinothorax haematocrit -haemothorax bilirubin gut perforation. Fluid samples 1st Plain Universal ( cell count) Examination Purpose of test Sample 17725 Fluid Profile (appearance, culture, WBC differential, ph, total protein, glucose, amylase, triglyceride, albumin, HDL) Peritoneal/ascitic and pleural fluid are

More information

Ascites. Matthew Johnson M.D.

Ascites. Matthew Johnson M.D. Ascites Matthew Johnson M.D. The most common complication of portal hypertension 50% of patients who have compensated cirrhosis develop ascites by 10 years Survival after ascites develops: 1-year: 85%

More information

Diagnostic feature of tuberculous peritonitis in patients with cirrhosis: A matched case control study

Diagnostic feature of tuberculous peritonitis in patients with cirrhosis: A matched case control study 1028 Diagnostic feature of tuberculous peritonitis in patients with cirrhosis: A matched case control study HAI JUN HUANG 1, JIN YANG 2,3, YI CHENG HUANG 1, HONG YING PAN 1, HONG WANG 1 and ZHUO CHAO REN

More information

Management of Pleural Effusion

Management of Pleural Effusion Management of Pleural Effusion Development of Pleural Effusion pulmonary capillary pressure (CHF) capillary permeability (Pneumonia) intrapleural pressure (atelectasis) plasma oncotic pressure (hypoalbuminemia)

More information

Serous fluids. Dr. Mohamed Saad Daoud

Serous fluids. Dr. Mohamed Saad Daoud Serous fluids 1 Reference Books: Urinanalysis and body fluids (Susan King Strasinger- Marjorie Schaub De Lorenzo) Fifth edition 2 The closed cavities of the body namely, the pleural, pericardial, and peritoneal

More information

Ascites and Related Disorders. Luis S. Marsano, MD Professor of Medicine Director of Hepatology University of Louisville 2016

Ascites and Related Disorders. Luis S. Marsano, MD Professor of Medicine Director of Hepatology University of Louisville 2016 Ascites and Related Disorders Luis S. Marsano, MD Professor of Medicine Director of Hepatology University of Louisville 2016 Causes of Ascites Malignant Neoplasia 10% Cardiac Insufficiency 3% Chronic hepatic

More information

Investigating the patient with ascites

Investigating the patient with ascites MODERN MEDICINE CPD ARTICLE NUMBER FOUR: 1 point Investigating the patient with ascites JELICA KURTOVIC, BSc (Med), MB BS; INDIRA SINGHGREWAL, BSc(Med), MB BS; STEVEN RIORDAN, MD, FRACP; Series Editor;

More information

Validation of Reagent Strips, Comparing with Automated and Manual Cell Counts for the Diagnosis of Spontaneous Bacterial Peritonitis ABSTRACT

Validation of Reagent Strips, Comparing with Automated and Manual Cell Counts for the Diagnosis of Spontaneous Bacterial Peritonitis ABSTRACT Original Article 91 Validation of Reagent Strips, Comparing with Automated and Manual Cell Counts for the Diagnosis of Spontaneous Bacterial Peritonitis Limmathurotsakul D 1 Bhokaisawan N 2 Thaimai P 1

More information

Cirrhosis and Portal Hypertension Gastroenterology Teaching Project American Gastroenterological Association

Cirrhosis and Portal Hypertension Gastroenterology Teaching Project American Gastroenterological Association CIRRHOSIS AND PORTAL HYPERTENSION Cirrhosis and Portal Hypertension Gastroenterology Teaching Project American Gastroenterological Association WHAT IS CIRRHOSIS? What is Cirrhosis? DEFINITION OF CIRRHOSIS

More information

Are we adequately screening at-risk patients for hepatocellular carcinoma in the outpatient setting?

Are we adequately screening at-risk patients for hepatocellular carcinoma in the outpatient setting? Rajani Sharma, PGY1 Geriatrics CRC Project, 12/19/13 Are we adequately screening at-risk patients for hepatocellular carcinoma in the outpatient setting? A. Study Purpose and Rationale Hepatocellular carcinoma

More information

Validation of Clinical Outcomes in Electronic Data Sources

Validation of Clinical Outcomes in Electronic Data Sources Validation of Clinical Outcomes in Electronic Data Sources Vincent Lo Re, MD, MSCE Assistant Professor of Medicine and Epidemiology Center for Clinical Epidemiology and Biostatistics Center for Pharmacoepidemiology

More information

Ascites, a New Cause for Bilateral Hydronephrosis: Case Report

Ascites, a New Cause for Bilateral Hydronephrosis: Case Report Case Study TheScientificWorldJOURNAL (2009) 9, 1035 1039 TSW Urology ISSN 1537-744X; DOI 10.1100/tsw.2009.112 Ascites, a New Cause for Bilateral Hydronephrosis: Case Report D. Jain*, S. Dorairajan, and

More information

ASCITES. Dr KS Cheung Queen Mary Hospital

ASCITES. Dr KS Cheung Queen Mary Hospital ASCITES Dr KS Cheung Queen Mary Hospital Outline Pathophysiology Differential diagnosis of ascites Diagnostic paracentesis Ascitic fluid analysis Management of Ascites Management of spontaneous bacterial

More information

Diseases of liver. Dr. Mohamed. A. Mahdi 4/2/2019. Mob:

Diseases of liver. Dr. Mohamed. A. Mahdi 4/2/2019. Mob: Diseases of liver Dr. Mohamed. A. Mahdi Mob: 0123002800 4/2/2019 Cirrhosis Cirrhosis is a complication of many liver disease. Permanent scarring of the liver. A late-stage liver disease. The inflammation

More information

Screening for hepatocellular carcinoma (HCC) is controversial.

Screening for hepatocellular carcinoma (HCC) is controversial. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2007;5:508 512 Screening for Hepatocellular Carcinoma Among Veterans With Hepatitis C on Disease Stage, Treatment Received, and Survival LUCI K. LEYKUM,* HASHEM

More information

Diagnostic Value of Leucocyte Esterase Reagent Strip Test in Cirrhotic Patients with Ascites for Early Detection of Spontaneous Bacterial Peritonitis

Diagnostic Value of Leucocyte Esterase Reagent Strip Test in Cirrhotic Patients with Ascites for Early Detection of Spontaneous Bacterial Peritonitis Diagnostic Value of Leucocyte Esterase Reagent Strip Test in Cirrhotic Patients with Ascites for Early Detection of Spontaneous Bacterial Peritonitis Sunil Agrawal, Barjatya H.C. Introduction The word

More information

Study On Ascitic Fluid Complement3 Level In Cirrhotic Patients With Spontaneous Bacterial Peritonitis And Without Spontaneous Bacterial Peritonitis

Study On Ascitic Fluid Complement3 Level In Cirrhotic Patients With Spontaneous Bacterial Peritonitis And Without Spontaneous Bacterial Peritonitis ISPUB.COM The Internet Journal of Gastroenterology Volume 6 Number 1 Study On Ascitic Fluid Complement3 Level In Cirrhotic Patients With Spontaneous Bacterial Peritonitis And Without Spontaneous Bacterial

More information

Diagnostic Approach to Pleural Effusion

Diagnostic Approach to Pleural Effusion Original Article GCSMC J Med Sci Vol (IV) No (I) January-June 2015 Diagnostic Approach to Pleural Effusion Rushi Patel*, Viral Shah*, Deepali Kamdar** Abstract : Aim : Normally the pleural cavities contain

More information

Different characteristics of tuberculous pleural effusion according to pleural fluid cellular predominance and loculation

Different characteristics of tuberculous pleural effusion according to pleural fluid cellular predominance and loculation Original Article Different characteristics of tuberculous pleural effusion according to pleural fluid cellular predominance and loculation Jaehee Lee 1, Jae Kwang Lim 2, Seung Soo Yoo 1, Shin Yup Lee 1,

More information

Differentiation Between Ileocecal Tuberculosis and Crohn s Disease using a Combination of Clinical, Endoscopic and Histological Characteristics

Differentiation Between Ileocecal Tuberculosis and Crohn s Disease using a Combination of Clinical, Endoscopic and Histological Characteristics 38 Original Article Differentiation Between Ileocecal Tuberculosis and Crohn s Disease using a Combination of Clinical, Endoscopic and Histological Characteristics Anuchapreeda S Leelakusolvong S Charatcharoenwitthaya

More information

Chylous ascites caused by acute pancreatitis with portal vein thrombosis

Chylous ascites caused by acute pancreatitis with portal vein thrombosis J Korean Surg Soc 2011;81:S64-68 http://dx.doi.org/10.4174/jkss.2011.81.suppl1.s64 CASE REPORT JKSS Journal of the Korean Surgical Society pissn 2233-7903 ㆍ eissn 2093-0488 Chylous ascites caused by acute

More information

During the past 2 decades, an increase in the ageadjusted

During the past 2 decades, an increase in the ageadjusted CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2006;4:104 110 Racial Differences in Survival of Hepatocellular Carcinoma in the United States: A Population-Based Study JESSICA A. DAVILA* and HASHEM B. EL SERAG*,

More information

Surveillance for HCC Who, how Diagnosis of HCC Surveillance for HCC in Practice

Surveillance for HCC Who, how Diagnosis of HCC Surveillance for HCC in Practice Surveillance for Hepatocellular Carcinoma Hashem B. El-Serag, MD, MPH Dan L. Duncan Professor of Medicine Chief, Gastroenterology and Hepatology Houston VA & Baylor College of Medicine Houston, TX Outline

More information

Prof. Mohammad Umar. MBBS, MCPS, FCPS, FACG (USA), FRCP (London), FRCP (Glasgow), FAGA

Prof. Mohammad Umar. MBBS, MCPS, FCPS, FACG (USA), FRCP (London), FRCP (Glasgow), FAGA Prof. Mohammad Umar MBBS, MCPS, FCPS, FACG (USA), FRCP (London), FRCP (Glasgow), FAGA Chairman and Head Department of Medicine Rawalpindi Medical College, Rawalpindi. Consultant Gastroenterologist / Hepatologist

More information

Radiology Update 2017

Radiology Update 2017 Radiology Update 2017 John K. Phillips, MD Affiliated Assistant Professor of Radiology University of Tennessee Health Sciences Center Chief, Radiology and Nuclear Medicine VA Memphis Disclosures Financial:

More information

Combined efficacy of pleural fluid lymphocyte neutrophil ratio and pleural fluid adenosine deaminase for the diagnosis of tubercular pleural effusion

Combined efficacy of pleural fluid lymphocyte neutrophil ratio and pleural fluid adenosine deaminase for the diagnosis of tubercular pleural effusion Original article: Combined efficacy of pleural fluid lymphocyte neutrophil ratio and pleural fluid adenosine deaminase for the diagnosis of tubercular pleural effusion Kavita S Kore, Guruprasad Antin,

More information

Profile of Tuberculosis Infection among Current HIV+ Patients at the Philippine General Hospital

Profile of Tuberculosis Infection among Current HIV+ Patients at the Philippine General Hospital Profile of Tuberculosis Infection among Current HIV+ Patients at the Albert B. Albay Jr., MD Jemylyn Garcia, MD Joel Santiaguel, MD UP- TB in the Philippines 6 th leading cause of morbidity and mortality

More information

DISEASE LEVEL MEDICAL EVIDENCE PROTOCOL

DISEASE LEVEL MEDICAL EVIDENCE PROTOCOL DISEASE LEVEL MEDICAL EVIDENCE PROTOCOL 1. This Protocol sets out the medical evidence that must be delivered to the Administrator for proof of Disease Level. It is subject to such further and other Protocols

More information

The Role of Likelihood Ratio in Clinical Diagnosis: Applicability in the Setting of Spontaneous Bacterial Peritonitis

The Role of Likelihood Ratio in Clinical Diagnosis: Applicability in the Setting of Spontaneous Bacterial Peritonitis CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2005;3:85 89 EVIDENCE-BASED MEDICINE The Role of Likelihood Ratio in Clinical Diagnosis: Applicability in the Setting of Spontaneous Bacterial Peritonitis FERNANDO

More information

The role of non-invasivemethods in evaluating liver fibrosis of patients with non-alcoholic steatohepatitis

The role of non-invasivemethods in evaluating liver fibrosis of patients with non-alcoholic steatohepatitis The role of non-invasivemethods in evaluating liver fibrosis of patients with non-alcoholic steatohepatitis Objectives: Liver biopsy is the gold standard for diagnosing the extent of fibrosis in NAFLD/NASH;

More information

Chylous Ascites in a Patient with Sepsis Caused by Bilateral Pneumonia

Chylous Ascites in a Patient with Sepsis Caused by Bilateral Pneumonia Korean J Crit Care Med 2014 August 29(3):217-221 / http://dx.doi.org/10.4266/kjccm.2014.29.3.217 ISSN 2383-4870 (Print) ㆍ ISSN 2383-4889 (Online) Case Report Chylous Ascites in a Patient with Sepsis Caused

More information

Management of Chronic Liver Failure/Cirrhosis Complications in Hospitals. By: Dr. Kevin Dolehide

Management of Chronic Liver Failure/Cirrhosis Complications in Hospitals. By: Dr. Kevin Dolehide Management of Chronic Liver Failure/Cirrhosis Complications in Hospitals By: Dr. Kevin Dolehide Overview DX Cirrhosis and Prognosis Compensated Decompensated Complications Of Cirrhosis Management Of Complications

More information

CLINICAL APPROACH TO ASCITES. Dr Lui Hock Foong FRCP, FAMS (Gastroenterology)

CLINICAL APPROACH TO ASCITES. Dr Lui Hock Foong FRCP, FAMS (Gastroenterology) CLINICAL APPROACH TO ASCITES Dr Lui Hock Foong FRCP, FAMS (Gastroenterology) CLINICAL PRESENTATION De Novo OR during follow-up of chronic disease Presentation: Increased abdominal girth, abdominal distension

More information

HEPATOrenal Syndrome Type I: Correct Diagnosis = Correct Management

HEPATOrenal Syndrome Type I: Correct Diagnosis = Correct Management HEPATOrenal Syndrome Type I: Correct Diagnosis = Correct Management Stephen G. M. Wong BSc, BSc(Med), MD, MHSc, FRCPC Associate Professor of Medicine Director, Hepatology Education Section of Hepatology

More information

Clinical, Diagnostic, and Operative Correlation of Acute Abdomen

Clinical, Diagnostic, and Operative Correlation of Acute Abdomen Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2018/163 Clinical, Diagnostic, and Operative Correlation of Acute Abdomen Madipeddi Venkanna 1, Doolam Srinivas 2, Budida

More information

The role of ARFI and APRI in diagnosis of liver fibrosis on patients with common chronic liver diseases

The role of ARFI and APRI in diagnosis of liver fibrosis on patients with common chronic liver diseases RESEARCH ARTICLE The role of ARFI and APRI in diagnosis of liver fibrosis on patients with common chronic liver diseases Objective: This study aimed to investigate the value of liver fibrosis assessment

More information

Diagnostic Approach to Pleural Effusion

Diagnostic Approach to Pleural Effusion Diagnostic Approach to Pleural Effusion Objectives Define the leading causes of pleural effusion Classify the type of effusion Identify procedures and tests associated with diagnosis 2 Agenda Basic anatomy

More information

The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases

The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases Alimentary Pharmacology & Therapeutics The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases J. R. KRAMER*,, J.A.DAVILA*,, E.D.MILLER*,, P.RICHARDSON*,,

More information

Myxoedema: A rare cause of massive ascites

Myxoedema: A rare cause of massive ascites www.edoriumjournals.com CASE REPORT PEER REVIEWED OPEN ACCESS Myxoedema: A rare cause of massive ascites Rabab Fouad, Mohamed B. Hashem, Mohamed Said, Marwa Khairy, Mahmoud Abouelkhair, A. A. Helmy ABSTRACT

More information

Liver Transplantation Evaluation: Objectives

Liver Transplantation Evaluation: Objectives Liver Transplantation Evaluation: Essential Work-Up Curtis K. Argo, MD, MS VGS/ACG Regional Postgraduate Course Williamsburg, VA September 13, 2015 Objectives Discuss determining readiness for transplantation

More information

Hepatitis C: Management of Previous Non-responders with First Line Protease Inhibitors

Hepatitis C: Management of Previous Non-responders with First Line Protease Inhibitors Hepatitis C: Management of Previous Non-responders with First Line Protease Inhibitors Fred Poordad, MD The Texas Liver Institute Clinical Professor of Medicine University of Texas Health Science Center

More information

To study the combined use of pleural fluid lymphocyte/ neutrophil ratio and ADA for the diagnosis of tuberculous pleural effusion

To study the combined use of pleural fluid lymphocyte/ neutrophil ratio and ADA for the diagnosis of tuberculous pleural effusion and ADA for the diagnosis of tuberculous. IAIM, 2017; 4(9): 1-5. Original Research Article To study the combined use of fluid lymphocyte/ neutrophil ratio and ADA for the diagnosis of tuberculous Ramasamy

More information

INCIDENCE OF BACTERIAL INFECTIONS IN CIRRHOSIS

INCIDENCE OF BACTERIAL INFECTIONS IN CIRRHOSIS INCIDENCE OF BACTERIAL INFECTIONS IN CIRRHOSIS Yoshida H et al (1993)* Deschenes M et al (1999)** Strauss E et al (1993) Borzio M et al (2002) PATIENTS 1140 140 170 405 INFECTIONS 15.4% 20% 47% 34% * Many

More information

Management of Cirrhotic Complications Uncontrolled Ascites. Siwaporn Chainuvati, MD Siriraj Hospital Mahidol University

Management of Cirrhotic Complications Uncontrolled Ascites. Siwaporn Chainuvati, MD Siriraj Hospital Mahidol University Management of Cirrhotic Complications Uncontrolled Ascites Siwaporn Chainuvati, MD Siriraj Hospital Mahidol University Topic Definition, pathogenesis Current therapeutic options Experimental treatments

More information

The ROBINS-I tool is reproduced from riskofbias.info with the permission of the authors. The tool should not be modified for use.

The ROBINS-I tool is reproduced from riskofbias.info with the permission of the authors. The tool should not be modified for use. Table A. The Risk Of Bias In Non-romized Studies of Interventions (ROBINS-I) I) assessment tool The ROBINS-I tool is reproduced from riskofbias.info with the permission of the auths. The tool should not

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Long GV, Hauschild A, Santinami M, et al. Adjuvant dabrafenib

More information

Hepatitis Alert: Management of Patients With HCV Who Have Achieved SVR

Hepatitis Alert: Management of Patients With HCV Who Have Achieved SVR Hepatitis Alert: Management of Patients With HCV Who Have Achieved SVR This program is supported by educational grants from AbbVie, Gilead Sciences, and Merck About These Slides Please feel free to use,

More information

Dr. A.Torossian, M.D., Ph. D. Department of Respiratory Diseases

Dr. A.Torossian, M.D., Ph. D. Department of Respiratory Diseases Pleural effusions Dr. A.Torossian, M.D., Ph. D. Department of Respiratory Diseases A pleural effusion is an abnormal collection of fluid in the pleural space resulting from excess fluid production or decreased

More information

Atypical Pleural Fluid Profiles in Tuberculous Pleural Effusion: Sequential Changes Compared with Parapneumonic and Malignant Pleural Effusions

Atypical Pleural Fluid Profiles in Tuberculous Pleural Effusion: Sequential Changes Compared with Parapneumonic and Malignant Pleural Effusions ORIGINAL ARTICLE Atypical Pleural Fluid Profiles in Tuberculous Pleural Effusion: Sequential Changes Compared with Parapneumonic and Malignant Pleural Effusions Chang Ho Kim, So Yeon Lee, Yong Dae Lee,

More information

CIRROSI E IPERTENSIONE PORTALE NELLA DONNA

CIRROSI E IPERTENSIONE PORTALE NELLA DONNA Cagliari, 16 settembre 2017 CIRROSI E IPERTENSIONE PORTALE NELLA DONNA Vincenza Calvaruso, MD, PhD Ricercatore di Gastroenterologia Gastroenterologia & Epatologia, Di.Bi.M.I.S. Università degli Studi di

More information

Wilson Disease Patient Lab Tracker

Wilson Disease Patient Lab Tracker Wilson Disease Patient Lab Tracker June, 2006 WDA Medical Advisory Committee Michael L. Schilsky M.D., Chair WILSON DISEASE PATIENT LAB TRACKER TREATMENT AND MONITORING OF WILSON DISEASE The following

More information

Pleural fluid analysis

Pleural fluid analysis Pleural fluid analysis Dr Akash Verma Senior Consultant- Department of Respiratory and Critical Care Medicine Tan Tock Seng Hospital, Singapore 308433 Adj A/Professor- Lee Kong Chian School of Medicine

More information

Long-term Clinical Outcomes and Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with HBsAg Seroclearance

Long-term Clinical Outcomes and Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with HBsAg Seroclearance Long-term Clinical Outcomes and Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with HBsAg Seroclearance Gi-Ae Kim, Han Chu Lee *, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim,

More information

Trends in the Burden of Nonalcoholic Fatty Liver Disease in a United States Cohort of Veterans

Trends in the Burden of Nonalcoholic Fatty Liver Disease in a United States Cohort of Veterans Clinical Gastroenterology and Hepatology 2016;14:301 308 Trends in the Burden of Nonalcoholic Fatty Liver Disease in a United States Cohort of Veterans Fasiha Kanwal,*,, Jennifer R. Kramer,*, Zhigang Duan,*,

More information

T he incidence of hepatocellular carcinoma (HCC) has

T he incidence of hepatocellular carcinoma (HCC) has 533 LIVER Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study J A Davila, R O Morgan, Y Shaib, K A McGlynn, H B El-Serag... See end of article

More information

Beta-blockers in cirrhosis: Cons

Beta-blockers in cirrhosis: Cons Beta-blockers in cirrhosis: Cons Eric Trépo MD, PhD Dept. of Gastroenterology. Hepatopancreatology and Digestive Oncology. C.U.B. Hôpital Erasme. Université Libre de Bruxelles. Bruxelles. Belgium Laboratory

More information

A Case Report of Acute Renal Artery Occlusion Mimicking Acute Appendicitis

A Case Report of Acute Renal Artery Occlusion Mimicking Acute Appendicitis ISPUB.COM The Internet Journal of Surgery Volume 7 Number 1 A Case Report of Acute Renal Artery Occlusion Mimicking Acute Appendicitis S Abouel-Enin, A Douglas, R Morgan Citation S Abouel-Enin, A Douglas,

More information

following the last documented transfusion; thereafter, evaluate the residual impairment(s).

following the last documented transfusion; thereafter, evaluate the residual impairment(s). Adult Listings 5.01 Category of Impairments, Digestive System 5.02 Gastrointestinal hemorrhaging from any cause, requiring blood transfusion (with or without hospitalization) of at least 2 units of blood

More information

Pleural Fluid Analysis: Back to Basics

Pleural Fluid Analysis: Back to Basics Pleural Fluid Analysis: Back to Basics Tonya L. Page, MSN, RN, ACNP-BC Patrick A. Laird, DNP, RN, ACNP-BC 70 y/o female with complaints of shortness of breath and orthopnea for 1 month. Symptoms have worsened

More information

Ammonia level at admission predicts in-hospital mortality for patients with alcoholic hepatitis

Ammonia level at admission predicts in-hospital mortality for patients with alcoholic hepatitis Gastroenterology Report, 5(3), 2017, 232 236 doi: 10.1093/gastro/gow010 Advance Access Publication Date: 1 May 2016 Original article ORIGINAL ARTICLE Ammonia level at admission predicts in-hospital mortality

More information

Liver Transplantation: The End of the Road in Chronic Hepatitis C Infection

Liver Transplantation: The End of the Road in Chronic Hepatitis C Infection University of Massachusetts Medical School escholarship@umms UMass Center for Clinical and Translational Science Research Retreat 2012 UMass Center for Clinical and Translational Science Research Retreat

More information

Home Intravenous Antibiotic Treatment for Intractable Cholangitis in Biliary Atresia

Home Intravenous Antibiotic Treatment for Intractable Cholangitis in Biliary Atresia Home Intravenous Antibiotic Treatment for Intractable Cholangitis in Biliary Atresia Hye Kyung Chang, Jung-Tak Oh, Seung Hoon Choi, Seok Joo Han Division of Pediatric Surgery, Department of Surgery, Yonsei

More information

Anaesthetic considerations and peri-operative risks in patients with liver disease

Anaesthetic considerations and peri-operative risks in patients with liver disease Anaesthetic considerations and peri-operative risks in patients with liver disease Dr. C. K. Pandey Professor & Head Department of Anaesthesiology & Critical Care Medicine Institute of Liver and Biliary

More information

Adenosine deaminase activity in tuberculous peritonitis among patients with underlying liver cirrhosis

Adenosine deaminase activity in tuberculous peritonitis among patients with underlying liver cirrhosis Online Submissions: http://www.wjgnet.com/esps/ wjg@wjgnet.com doi:10.3748/wjg.v18.i37.5260 World J Gastroenterol 2012 October 7; 18(37): 5260-5265 ISSN 1007-9327 (print) ISSN 2219-2840 (online) 2012 Baishideng.

More information

Hepatocytes produce. Proteins Clotting factors Hormones. Bile Flow

Hepatocytes produce. Proteins Clotting factors Hormones. Bile Flow R.J.Bailey MD Hepatocytes produce Proteins Clotting factors Hormones Bile Flow Trouble.. for the liver! Trouble for the Liver Liver Gall Bladder Common Alcohol Hep C Fatty Liver Cancer Drugs Viruses Uncommon

More information

Transient elastography in chronic liver diseases of other etiologies

Transient elastography in chronic liver diseases of other etiologies 4 Post Meeting A.I.S.F. Unmet Clinical Needs in Hepatology: New and upcoming diagnostic tools" Transient elastography in chronic liver diseases of other etiologies Dr. Vincenza Calvaruso Gastroenterologia

More information

Hepatology for the Nonhepatologist

Hepatology for the Nonhepatologist Hepatology for the Nonhepatologist Kenneth E. Sherman, MD, PhD Gould Professor of Medicine Director, Division of Digestive Diseases University of Cincinnati College of Medicine Cincinnati, Ohio Learning

More information

Patients with compensated cirrhosis: how to treat and follow-up

Patients with compensated cirrhosis: how to treat and follow-up Patients with compensated cirrhosis: how to treat and follow-up Thomas Berg Sektion Hepatologie Klinik und Poliklinik für Gastroenterologie und Rheumatologie Universitätsklinikum Leipzig Leber- und Studienzentrum

More information

Manejo Práctico del Derrame Pleural

Manejo Práctico del Derrame Pleural Manejo Práctico del Derrame Pleural San José, Costa Rica Junio 29, 2017 Rodrigo Cartín Ceba, MD, MSc Consultant, Pulmonary and Critical Care Medicine Associate Professor of Medicine Mayo Clinic 2010 MFMER

More information

Ascitic fluid analysis with special reference to serum ascites cholesterol gradient and serum ascites albumin gradient

Ascitic fluid analysis with special reference to serum ascites cholesterol gradient and serum ascites albumin gradient International Journal of Research in Medical Sciences Sastry AS et al. Int J Res Med Sci. 2017 Feb;5(2):429-436 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Original Research Article DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20170059

More information

Abnormal abdominal ultrasound icd 10

Abnormal abdominal ultrasound icd 10 Abnormal abdominal ultrasound icd 10 The Borg System is 100 % Abnormal abdominal ultrasound icd 10 (R10.0) Acute abdomen; (R10.1) Pain localized to upper abdomen; (R10.2) Pelvic and perineal pain; (R10.3)

More information

Investigations before OLT, Immunosuppression and rejection, Follow up after OLT.

Investigations before OLT, Immunosuppression and rejection, Follow up after OLT. Investigations before OLT, Immunosuppression and rejection, Follow up after OLT andrea.degottardi@insel.ch When is liver transplantation indicated? When is liver transplantation indicated? Frequent: CIRRHOSIS

More information

HEPATOCELLULAR CARCINOMA: SCREENING, DIAGNOSIS, AND TREATMENT

HEPATOCELLULAR CARCINOMA: SCREENING, DIAGNOSIS, AND TREATMENT HEPATOCELLULAR CARCINOMA: SCREENING, DIAGNOSIS, AND TREATMENT INTRODUCTION: Hepatocellular carcinoma (HCC): Fifth most common cancer worldwide Third most common cause of cancer mortality In Egypt: 2.3%

More information

Effects of probiotics in the treatment of alcoholic hepatitis: randomized controlled multicenter study

Effects of probiotics in the treatment of alcoholic hepatitis: randomized controlled multicenter study Effects of probiotics in the treatment of alcoholic hepatitis: randomized controlled multicenter study Lactobacillus subtilis/streptococcus faecium Lactobacillus rhamnosus R0011/acidophilus R0052 Ki Tae

More information

Diagnosis of Spontaneous Bacterial Peritonitis by Identification of 16s rrna Genes in Liver Cirrhosis Patients

Diagnosis of Spontaneous Bacterial Peritonitis by Identification of 16s rrna Genes in Liver Cirrhosis Patients Med. J. Cairo Univ., Vol. 83, No. 2, December: 209-214, 2015 www.medicaljournalofcairouniversity.net Diagnosis of Spontaneous Bacterial Peritonitis by Identification of 16s rrna Genes in Liver Cirrhosis

More information

ROLE OF COMPUTED TOMOGRAPHY IN EVALUATION OF ASCITES Ramesh Chander 1, Kamlesh Gupta 2, Arvinder Singh 3, V. K. Rampal 4, Mohit Khandelwal 5

ROLE OF COMPUTED TOMOGRAPHY IN EVALUATION OF ASCITES Ramesh Chander 1, Kamlesh Gupta 2, Arvinder Singh 3, V. K. Rampal 4, Mohit Khandelwal 5 ROLE OF COMPUTED TOMOGRAPHY IN EVALUATION OF ASCITES Ramesh Chander 1, Kamlesh Gupta 2, Arvinder Singh 3, V. K. Rampal 4, Mohit Khandelwal 5 HOW TO CITE THIS ARTICLE: Ramesh Chander, Kamlesh Gupta, Arvinder

More information

Pleural Effusions. Kyle J Henry, MD Pulmonary/ CCM Fellow PGY4 (210) (602)

Pleural Effusions. Kyle J Henry, MD Pulmonary/ CCM Fellow PGY4 (210) (602) Pleural Effusions Kyle J Henry, MD Pulmonary/ CCM Fellow PGY4 (210) 275 8583 (602) 202 0351 None Disclosures Objectives Understand the presentation of a pleural effusion How to diagnose and treat Differentiate

More information

Laboratory Tests and Diagnostic Procedures in Liver Disease: Adventures in Liverland

Laboratory Tests and Diagnostic Procedures in Liver Disease: Adventures in Liverland Laboratory Tests and Diagnostic Procedures in Liver Disease: Adventures in Liverland Sanjiv Chopra, MD, MACP Professor of Medicine Harvard Medical School Editor In Chief Hepatology Section Up To Date Serum

More information

Update on Nonalcoholic Fatty Liver Disease. Kathleen E Corey, MD, MPH, MMSc Director, Mass General Fatty Liver Clinic

Update on Nonalcoholic Fatty Liver Disease. Kathleen E Corey, MD, MPH, MMSc Director, Mass General Fatty Liver Clinic Update on Nonalcoholic Fatty Liver Disease Kathleen E Corey, MD, MPH, MMSc Director, Mass General Fatty Liver Clinic Outline Defining the phenotypes of nonalcoholic fatty liver disease NAFLD Diagnostics

More information

South African HIV Clinicians Society Managing adult treatment through case study discussion

South African HIV Clinicians Society Managing adult treatment through case study discussion South African HIV Clinicians Society Managing adult treatment through case study discussion Jade Mogambery Grey s Hospital, Pietermaritzburg Infectious Diseases Unit Referral summary 20-year-old male HIV

More information

Clinical guidelines for the treatment of hepatitis C in Iceland

Clinical guidelines for the treatment of hepatitis C in Iceland F the Treatment as Prevention f Hepatitis C in Iceland (TraP Hep C) A nationwide campaign f reducing disease burden using combination antiviral treatment Whom to treat All patients infected with the hepatitis

More information

Surveillance for Hepatocellular Carcinoma

Surveillance for Hepatocellular Carcinoma Surveillance for Hepatocellular Carcinoma Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco Recorded on April

More information

Evaluation of tumor markers for the differential diagnosis of benign and malignant ascites

Evaluation of tumor markers for the differential diagnosis of benign and malignant ascites ORIGINAL ARTICLE May-June, Vol. 13 No. 3, 2014: 357-363 Evaluation of tumor markers for the differential diagnosis of benign and malignant ascites Fang Liu,*, Xinjuan Kong,**, Qian Dou,** Jin Ye,*** Dong

More information

ORIGINAL ARTICLES LIVER, PANCREAS, AND BILIARY TRACT

ORIGINAL ARTICLES LIVER, PANCREAS, AND BILIARY TRACT CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2011;9:989 994 ORIGINAL ARTICLES LIVER, PANCREAS, AND BILIARY TRACT Level of -Fetoprotein Predicts Mortality Among Patients With Hepatitis C Related Hepatocellular

More information

Most persons who acquire hepatitis C virus

Most persons who acquire hepatitis C virus AMERICAN ASSOCIATION FOR THE STUDY OFLIVERD I S E ASES HEPATOLOGY, VOL. 64, NO. 1, 2016 Risk of Hepatocellular Carcinoma After Sustained Virological Response in Veterans With Hepatitis C Virus Infection

More information

Accepted Manuscript. Unexpected high incidence of hepatocellular carcinoma in patients with hepatitis C in the era of DAAs: too alarming?

Accepted Manuscript. Unexpected high incidence of hepatocellular carcinoma in patients with hepatitis C in the era of DAAs: too alarming? Accepted Manuscript Unexpected high incidence of hepatocellular carcinoma in patients with hepatitis C in the era of DAAs: too alarming? Qing-Lei Zeng, Zhi-Qin Li, Hong-Xia Liang, Guang-Hua Xu, Chun-Xia

More information

Serum - Ascites Albumin and Cholesterol Gradients in Differential Diagnosis of Ascites

Serum - Ascites Albumin and Cholesterol Gradients in Differential Diagnosis of Ascites Serum - Ascites Albumin and Cholesterol Gradients in Differential Diagnosis of Ascites Sapna Vyakaranam*, Srinivas Nori**, Gurumurthy Sastry M*, Sudhir Bhargav Vyakaranam, Aparna Varma Bhongir* * Department

More information